Cargando…

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children

Objective: To explore the effectiveness and safety of rituximab (RTX) for steroid-dependent or frequently relapsing nephrotic syndrome via a systematic review and meta-analysis. Methods: All the literature about RTX therapy for childhood nephrotic syndrome (NS) on PubMed, Web of Science, Cochrane Li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xia, Wang, Yan, Xu, Zichuan, Deng, Huiying, Yang, Huabin, Zhong, Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339375/ https://www.ncbi.nlm.nih.gov/pubmed/34368023 http://dx.doi.org/10.3389/fped.2021.626323

Ejemplares similares

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
por: Xiang, Xin, et al.
Publicado: (2021)

The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
por: Liu, Sidi, et al.
Publicado: (2021)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Clinico-Biochemical Profile and Identification of Independent Risk Factors of Frequent Relapse in Childhood-Onset Steroid-Sensitive Nephrotic Syndrome
por: Behera, Manas Ranjan, et al.
Publicado: (2022)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome
por: Casiraghi, Federica, et al.
Publicado: (2023)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
por: Wang, Li, et al.
Publicado: (2022)

Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience
por: Kuźma-Mroczkowska, Elżbieta, et al.
Publicado: (2016)

Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi
por: Moorani, Khemchand N, et al.
Publicado: (2020)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience
por: Moustafa, Bahia Hassan, et al.
Publicado: (2016)

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
por: Hogan, Julien, et al.
Publicado: (2020)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update
por: Lane, Brandon M., et al.
Publicado: (2019)

Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors
por: Beins, Nathan T., et al.
Publicado: (2015)

B Lymphocyte Subsets in Children With Steroid-Sensitive Nephrotic Syndrome: A Longitudinal Study
por: Ling, Chen, et al.
Publicado: (2021)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

CCL22 and Leptin associated with steroid resistance in childhood idiopathic nephrotic syndrome
por: Zhaoyang, Peng, et al.
Publicado: (2023)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Genetic Testing for Steroid-Resistant-Nephrotic Syndrome in an Outbred Population
por: Varner, Jennifer D., et al.
Publicado: (2018)

Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center
por: Alsaran, Khalid, et al.
Publicado: (2017)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials
por: Tan, Liping, et al.
Publicado: (2019)

Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis
por: Xue, Cheng, et al.
Publicado: (2020)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
por: Guzzi, Francesco, et al.
Publicado: (2020)

Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
por: Safdar, Osama Yousif, et al.
Publicado: (2022)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease
por: Guimarães, Fabio Tadeu Lourenço, et al.
Publicado: (2019)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Editorial: Nephrotic Syndrome in Children
por: Sanjad, Sami A., et al.
Publicado: (2021)

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
por: Nagano, China, et al.
Publicado: (2019)

Quality Improvement Initiative to Reduce Admissions for Nephrotic Syndrome Relapse in Pediatric Patients
por: Charnaya, Olga, et al.
Publicado: (2019)

Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry
por: Trautmann, Agnes, et al.
Publicado: (2018)

Prediction of steroid resistance and steroid dependence in nephrotic syndrome children
por: Zaorska, Katarzyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or331f3fl7cgmpeer43suo4enr